This finding also indicates that solid organ transplant recipients have weaker CD4+ and CD8+ T-cell responses compared to other groups of immunocompromised patients, such as primary immunodeficiency syndromes, AIDS, hematopoietic stem cell transplant recipients, and chronic lymphocytic leukemia patients. This evidence concerns the gene CD4 and AIDS.